Patent Assignment
Reel/Frame 055114/0843
Merger
Recorded: 2021-02-02
Pages: 12
Assignor
VGX PHARMACEUTICALS, LLC
Executed: 2020-12-31
Assignee
INOVIO PHARMACEUTICALS, INC.
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PENNSYLVANIA, 19462
Covered Properties
(34)
Administration of Nucleic Acid Sequence to Female Animal to Enhance Growth in Offspring
PCT:
PCT/US2001/048726 ↗
Reducing Culling in Herd Animals Growth Hormone Releasing Hormone (Ghrh)
PCT:
PCT/US2004/002134 ↗
Insulin-Like Growth Factor (Igf-I) Plasmid-Mediated Supplementation for Therapeutic
PCT:
PCT/US2004/007295 ↗
Plasmid Mediated Ghrh Supplementation for Renal Failures
PCT:
PCT/US2004/012159 ↗
Canine Specific Growth Hormone Releasing Hormone
PCT:
PCT/US2004/023393 ↗
Constant Current Electroporation Device and Methods of Use
PCT:
PCT/US2004/028998 ↗
Reducing Arthritis and Lameness in Subjects by Growth Hormone Releasing Hormone (Ghrh) Supplementation
PCT:
PCT/US2004/042497 ↗
Enhanced Secretion/Retention of Growth Hormone Releasing Hormone (Ghrh) from Muscle Cells by Species-Specific Signal Peptide
PCT:
PCT/US2005/000892 ↗
Growth Hormone Releasing Hormone Enhances Vaccination Response
PCT:
PCT/US2005/025747 ↗
Electroporation Devices and Methods of Using Same for Electroporation of Cells in Mammals
PCT:
PCT/US2007/022139 ↗
Increased Stability of a Dna Formulation by Including Poly-L-Glutamate
PCT:
PCT/US2008/083785 ↗
Antigens That Elicit Immune Response Against Flavivirus and Methods of Using Same
PCT:
PCT/US2009/064726 ↗
Treating Anemia in Subjects by Administration of Plasmids Encoding Growth Hormone Releasing Hormone
Electrode Assembly for Constant-Current Electroporation and Use
Codon Optimized Synthetic Plasmids
Constant Current Electroporation Device and Methods of Use
Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
Canine Specific Growth Hormone Releasing Hormone
Reducing Arthritis and Lameness in Subjects by Growth Hormone Releasing Hormone (Ghrh) Supplementation
Enhanced Secretion / Retention of Growth Hormone Releasing Hormone (Ghrh) from Muscle Cells by Species-Specific Signal Peptide
Optimized High Yield Synthetic Plasmids
Electrode Assembly for Constant-Current Electroporation and Use
Gene Therapy Expression of Ghrh for Increasing Rbc Count in Subjects
Electroporation Devices and Methods of Using Same for Electroporation of Cells in Mammals
Antibody Production Elicited by a Dna Vaccine Delivered by Electroporation
Growth Hormone Releasing Hormone Treatment to Decrease Cholesterol Levels
COMPOSITIONS COMPRISING GHRH AND GnRH AND METHODS OF USING THE SAME
Optimized High Yield Synthetic Plasmids
Contactless Electropermeabilization Electrode and Method
Foot and Mouth Disease Virus (Fmdv) Consensus Proteins, Coding Sequences Therefor and Vaccines Made Therefrom
Foot and Mouth Disease Virus (FMDV) Consensus Proteins, Coding Sequences Therefor and Vaccines Made Therefrom
Contactless Electropermeabilization Electrode and Method
Application:
16/272,685 →
Publication:
US 2019/0167983
Foot and Mouth Disease Virus (FMDV) Consensus Proteins, Coding Sequences Therefor and Vaccines Made Therefrom
Foot and Mouth Disease Virus (Fmdv) Consensus Capsid Proteins as Immunogens and Vaccines Made Therefrom
Application:
61/257,450 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 9, 2012
From: DRAGHIA-AKLI, RUXANDRA; CARPENTER, ROBERT H; KERN, DOUGLAS R; KING, GLEN
To: ADVISYS INC.
Reel/Frame 028011/0207 →
Assignment of Assignor's Interest
Apr 9, 2012
From: SCHWARTZ, ROBERT J; BRENNER, MALCOLM K
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 028011/0255 →
Merger
Apr 9, 2012
From: ADVISYS INC.
To: VGX PHARMACEUTICALS, INC.
Reel/Frame 028011/0311 →
Merger and Change of Name
Dec 21, 2020
From: VGX PHARMACEUTICALS, INC.; INOVIO ACQUISITION, LLC
To: VGX PHARMACEUTICALS, LLC
Reel/Frame 054704/0830 →